SYNLAB France in the news
Medical diagnostic laboratory network
Tamtam found 16 recent articles about SYNLAB France.
- Bird & Bird advised SYNLAB France on the sale of SYNLAB Medical Digital Services to Nexus AG
SYNLAB France sold its digital services arm, SYNLAB Medical Digital Services, to Nexus AG, aiming to expand digital lab solutions across Europe.
- SYNLAB France Number of Employees 2026 | Employee Count & Headcount Data
SYNLAB France SAS is expected to have 594 employees worldwide by March 2026, marking a 3.5% decline from 616 employees in 2023.
- Cinven-backed Synlab seeks to raise €400 million in IPO
Laboratory services provider Synlab is launching an IPO in Frankfurt to raise 400 million euros following a surge in revenue from COVID-19 testing.
- The Synnovis cyber attack, glaring neglect, and business discontinuity
A ransomware attack on the Synnovis pathology network caused massive surgical delays in London, exposing critical failures in the company's disaster recovery and cybersecurity preparedness.
- SYNLAB delivers strong performance in Q1 2024
SYNLAB reported strong Q1 2024 financial results with increased revenue and adjusted EBITDA, confirming its full-year outlook and highlighting strategic progress following Cinven's acquisition.
- A New Blood Test to Differentiate Depression and Bipolar Disorders
A new blood-based RNA test being deployed across French laboratories significantly accelerates the differential diagnosis of bipolar disorders through AI and genetic sequencing.
- Synlab says French premises were raided by antitrust enforcers
Antitrust enforcers recently raided the French offices of Synlab as part of a regulatory investigation.
- SYNLAB launches revolutionary bipolar disorder diagnostic test: myEDIT-B
A new blood test called myEDIT-B provides rapid differential diagnosis of bipolar disorder to prevent common misdiagnosis and improve patient outcomes.
- Cinven to launch offer for Synlab shares
Cinven prepares a buyout offer for Synlab shares while Triton extends its pursuit of Caverion.
- SYNLAB enters into investment agreement relating to a public acquisition offer by Cinven
Cinven has entered an agreement to acquire all remaining shares of medical diagnostic leader SYNLAB for €10.00 each to support its long-term growth strategy.
- ALCEDIAG and SYNLAB join forces in Europe to fight diagnostic delay of bipolar disorder with the EDIT-Btm test
ALCEDIAG and SYNLAB launched EDIT-Btm, a CE-marked blood test to distinguish bipolar disorder from depression, aiming to reduce diagnostic delays.
- SYNLAB AG commences trading on the Frankfurt Stock Exchange
SYNLAB AG listed on the Frankfurt Stock Exchange after achieving a 4.0 billion euro valuation and expanding its medical diagnostic network across 36 countries.
- Nicolas Desjardins, président de Synlab Lorraine
Synlab Lorraine's leader details the laboratory's frontline diagnostic response to COVID-19 and its contribution to national serological testing standards.
- Thousands seek antibody blood tests in France
Major French laboratory networks are experiencing high demand for private COVID-19 antibody tests despite government caution and lack of reimbursement.
- Cinven buys medical operator Synlab for about $1.96bn
Private equity firm Cinven is acquiring Synlab for $1.96 billion to merge it with France-based Labco.
- Cinven to acquire the Synlab Group | Cinven - Focused European Integrated World-class
Cinven is merging Synlab with Labco to create a market-leading European medical diagnostics network across 26 countries.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like SYNLAB France?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies